|1||NCT04103567||Not yet recruiting
|Determination of Microbiological Factors Predicting Poor Response to Neoadjuvant Treatment in Rectal Cancers||
||220||All||18 Years and older (Adult, Older Adult)||NCT04103567||PROICM 2019-14-MIR||MICARE||November 2019||March 2023||November 2027||September 25, 2019||September 27, 2019|
|2||NCT03651271||Recruiting||Treatment With Nivolumab and Ipilimumab or Nivolumab Alone According to the Percentage of Tumoral CD8 Cells in Advanced Metastatic Cancer||
||Other / Industry||
||200||All||18 Years and older (Adult, Older Adult)||NCT03651271||PICI0025||October 17, 2018||September 14, 2020||September 14, 2022||August 29, 2018||May 30, 2019||
† Study has passed its completion date and status has not been verified in more than two years.